# PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

> **NCT06448286** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 60 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
- **PROCEDURE:** Contrast-enhanced Magnetic Resonance Imaging
- **PROCEDURE:** Magnetic Resonance Imaging
- **RADIATION:** Radiation Therapy
- **PROCEDURE:** Surgical Procedure
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT06448286
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2029-06-01
- **Final completion:** 2030-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06448286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06448286, "PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06448286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*